Certificate under 74(5) of SEBI DP Regulations 2018 for the quarter ended 31.03.2025
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lotus Eye Hospital's registrar and share transfer agent, MUFG Intime India Private Limited, has submitted a routine compliance certificate for the quarter ended 31 March 2025. The certificate confirms that all securities received from depository participants for dematerialisation during the quarter were properly accepted or rejected and listed on the stock exchanges. It also confirms that physical share certificates received for dematerialisation were mutilated and cancelled after verification, with the depository's name recorded as the registered owner in the company's register of members within prescribed timelines.
This is a standard procedural filing with no material impact on the company, its operations, or shareholder value. Investors can disregard this for any investment decision-making purposes.